Market Size of Asia Pacific Nuclear Imaging Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.52 Billion |
| Market Size (2029) | USD 1.88 Billion |
| CAGR (2024 - 2029) | 4.23 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
APAC Nuclear Imaging Devices Market Analysis
The Asia Pacific Nuclear Imaging Market size is estimated at USD 1.52 billion in 2024, and is expected to reach USD 1.88 billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029).
The factors that are propelling the growth of the market include technological advancements, increasing diagnostic applications in various diseases, such as cancer and cardiovascular diseases, and the growing burden of these chronic diseases.
Over recent years, scientists, researchers, and technologists have been able to bring systems in clinical practice, in which two or even more than two standalone diagnostic imaging modalities are combined. Some of those multimodality imaging systems include PET/CT, SPECT/CT, PET/MRI, and PET/SPECT/CT. The shift from standalone to hybrid modalities have improved the applications of these devices in recent times.
Moreover, the rise in the prevalence of cancer and cardiac ailments is one of the primary drivers for the market. Nuclear medicine is hugely capable of treating cancer and cardiac diseases. Asia Pacific region has the highest populous countries like China and India, which in turn contribute to a large aging population. There is also a higher disease incidence in this region increases the demand for advanced technologies like nuclear imaging. There is a large investment on the healthcare setup and medical research making these facilities accessible. The per capita income is increasing in these countries making such technologies more affordable.
